Showing results (71-80 of 279) with videos related to

Sort By:
Pageof 28
Cancer Chemotherapy and Pharmacology|December 5, 2006
A phase I pharmacodynamic study of the effects of the cyclin-dependent kinase-inhibitor AZD5438 on cell cycle markers within the buccal mucosa, plucked scalp hairs and peripheral blood mononucleocytes of healthy male volunteersD Ross Camidge, Mike Pemberton, Jim Growcott, et al.
Clinical Lung Cancer|June 5, 2018
Phase Ib Study of High-dose Intermittent Afatinib in Patients With Advanced Solid TumorsD Ross Camidge, Lecia V Sequist, Pasi A Jänne, et al.
Future Oncology (London, England)|March 2, 2022
Effectiveness of crizotinib versus entrectinib in ROS1-positive non-small-cell lung cancer using clinical and real-world dataGabriel Tremblay, Michael Groff, Laura Iadeluca, et al.
The Oncologist|May 8, 2025
Real-world treatment and outcomes for EGFR WT advanced/metastatic non-squamous non-small cell lung cancer: pooled analysis from project LUMINATE-101Nicolas Girard, Qingqing Xu, D Ross Camidge, et al.
Cancer|January 28, 2012
Correlations between the percentage of tumor cells showing an anaplastic lymphoma kinase (ALK) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization-positive nonsmall cell lung cancerD Ross Camidge, Mariana Theodoro, Delee A Maxson, et al.
Frontiers in Oncology|May 1, 2020
Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung CancerTejas Patil, Jose M Pacheco, Anastasios Dimou, et al.
Breast Cancer Research and Treatment|June 28, 2020
Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancerMichelle D Hackshaw, Heather E Danysh, Jasmeet Singh, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene statusTejas Patil, Dara L Aisner, Sinead A Noonan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2020
Prospective Observational Study Revealing Early Pulmonary Function Changes Associated With Brigatinib InitiationTerry L Ng, Amber Johnson, Raphael A Nemenoff, et al.
Translational Lung Cancer Research|August 25, 2021
A narrative review of primary research endpoints of neoadjuvant therapy for lung cancer: past, present and futureSijia Ren, Anyi Xu, Yilian Lin, et al.
Pageof 28